Graphical Abstract Highlights d Early exhausted T cells exhibit repressed glycolytic and mitochondrial metabolism d Metabolic skewing occurred despite mTOR-driven upregulation of anabolic pathways d PD-1 regulated bioenergetic insufficiencies early and late in infection d PGC-1a overexpression improved metabolism and T cell function
INTRODUCTION
Upon viral infection, naive virus-specific CD8 + T cells differentiate into effector T cells (Teff) that proliferate and produce antiviral effector proteins. To meet increased bioenergetic demands, these cells undergo metabolic reprogramming from quiescent mitochondrial oxidative phosphorylation (OXPHOS) to glycolysis (Buck et al., 2015) . With these metabolic changes, glucose use is directed away from mitochondria, fueling less efficient cytoplasmic energy production but simultaneously allowing the generation of cellular building blocks necessary for proliferation and macromolecular synthesis to meet the demand for increased biomass. In addition, switching to glycolysis is directly linked to increased effector function (Chang et al., 2013; Ho et al., 2015) . The change in metabolic lifestyle is thought to occur through T cell receptor (TCR)-linked, phosphoinositide 3-kinase (PI3K), and Akt-mediated mTOR signaling (Buck et al., 2015) . After acute resolving infections, such as with the Armstrong (Arm) strain of lymphocytic choriomeningitis virus (LCMV), the virusspecific T cell response contracts and a pool of memory T cells (Tmem) is established (Wherry and Kurachi, 2015) . The conversion to memory is characterized by a shift back to mitochondrial OXPHOS, fueled at least in part by fatty acid oxidation (O'Sullivan et al., 2014; van der Windt et al., 2012) .
In contrast to acute resolving viral infections, virus-specific T cell function is compromised in persisting infections, such as in hepatitis C virus (HCV), human immunodeficiency virus (HIV), or infection with the chronic clone 13 strain of LCMV in mice as well as in cancer (Wherry and Kurachi, 2015) . While there are similarities between the CD8 + Teff cell response in acute and chronic viral infections, virus-specific T cells in chronic infections can become progressively exhausted. Tex cells are defined by poor effector functions, high co-expression of multiple inhibitor receptors and an altered global transcriptional program compared to functional Teff or Tmem cells (Wherry and Kurachi, 2015) . In addition, two subsets of Tex cells exist that are defined by high expression of the transcription factor T-bet and intermediate expression of inhibitory receptor PD-1 (T-bet Hi PD-1 Int ) or high Eomesodermin (Eomes) and high PD-1 expression (Eomes Hi PD-1 Hi ). Whereas both subsets are required for control of chronic infection, the PD-1 Int subset functions as a progenitor pool giving rise to terminally differentiated PD-1 Hi cells . Targeted blockade of PD-1 is effective in improving T cell function and reducing viral replication, mainly by reinvigorating the PD-1 Int Tex cell subset (Blackburn et al., 2008) . Inhibitory receptor blockade targeting immune checkpoints is also transforming human cancer therapy with impressive responses in multiple types of malignancies presumably due to reversal of T cell exhaustion (Wolchok and Chan, 2014) .
Continued TCR signaling due to persisting antigen is thought to be a key driver of T cell exhaustion. One function of inhibitory receptors such as PD-1 is to attenuate signaling downstream of the TCR. The intracellular tail of PD-1 contains an immunotyrosine inhibitory motif (ITIM) and an immunotyrosine switch motif (ITSM), that can recruit phosphatases such as SHP-2, allowing dephosphorylation of key signal transducers (Chemnitz et al., 2004; Okazaki et al., 2001) . Engagement of PD-1 by its ligand PD-L1 results in the formation of microclusters with the TCR (Yokosuka et al., 2012) and PD-1 inhibits proximal signaling molecules after TCR engagement (Sheppard et al., 2004) . As a result, PD-1 can function as a rheostat to tune TCR signaling in tissues during infections (Honda et al., 2014; Okazaki et al., 2013) . In addition, PD-1 ligation attenuates PI3K and Akt signaling inhibiting cell cycle at the G1 stage (Patsoukis et al., 2012) . In vitro, engaging PD-1 or CTLA-4 on activated T cells reduces Akt and mTOR signaling, and suppresses glycolysis (Parry et al., 2005; Patsoukis et al., 2015) . In vivo, a feedback loop between PD-1 and the transcription factor Foxo1 exists that desensitizes antigen-induced signaling via the Akt and mTOR pathway, fostering survival of more terminally differentiated PD-1 Hi Eomes Hi Tex cells (Staron et al., 2014) . These data suggest that the PD-1 Int and PD-1 Hi Tex cell subsets might have different metabolic requirements. Thus, previous data suggest a role for inhibitory receptor signaling in metabolism of Tex cells. However, the mechanisms responsible for the regulation of the metabolic lifestyle of CD8 + Tex cells, when these metabolic changes occur, and the role of inhibitory receptors in this process in vivo remain to be fully defined.
Here, we examined these questions and demonstrate that functional metabolic derangement occurred early in the development of CD8 + T cell exhaustion. This early metabolic derangement included suppressed respiration, reduced glucose uptake, glycolysis, and dysregulated mitochondrial energetics. Elevated mTOR activity and PD-1 signaling early during the development of T cell exhaustion contributed to these metabolic alterations. PD-1 repressed expression of the key metabolic regulator PGC1-a in CD8 + T cells early during chronic infection and retroviral (RV) expression of PGC1-a corrected some metabolic alterations in developing Tex cells and improved effector function. These data highlight a key metabolic control event that occurs early during the development of exhaustion. Metabolic dysregulation was maintained into established chronic infection and was controlled, at least in part, by PD-1 because blockade of PD-1:PD-L1 interactions resulted in metabolic reprogramming of PD-1 Int Tex cells, but not the PD-1 Hi subset. Thus, targeting Tex cell metabolism might constitute an important aspect of immunomodulatory therapies and could complement effects of blocking PD-1 or other checkpoints.
RESULTS

Transcriptional Analysis Indicates Early Regulation of Metabolism in Tex Cells
Transcriptional profiling revealed relatively few differences in LCMV-specific CD8 + T cells responding to acutely cleared Arm versus the chronic clone 13 strains of LCMV in early infection (day 6 and day 8 post infection [p.i.]) compared to later time points (day 30+) ( Figure 1A ) (Crawford et al., 2014; Doering et al., 2012) . To examine whether metabolic pathways were regulated differently in CD8 + T cells prior to development of memory versus exhaustion, we first compared the gene-expression profiles of LCMV-specific CD8 + T cells from LCMV clone 13infected mice to those from Arm-infected mice at the peak of the effector response and after development of Tmem and Tex cells (day 8 versus day 30 p.i.) by gene-set enrichment analysis (GSEA). Genes involved in glycolysis were enriched in CD8 + T cells from Arm infection ( Figure 1B) . In contrast, genes involved in OXPHOS were enriched early during clone 13 infection (early Tex cells) ( Figure 1B) . A broader analysis showed enrichment for other metabolic pathways in early clone 13 infection, including citrate cycle, fatty acid (FA) metabolism and amino acid metabolism ( Figure 1C ). Leading edge analysis identified Cpt1a, the gene encoding a key enzyme fueling FA-driven mitochondrial OXPHOS, as highly enriched in clone 13 infection (Figure 1D) . In contrast, few metabolic pathways were enriched in LCMV-specific Teff from Arm infection. This pattern reversed at day 30 p.i., when CD8 + T cell exhaustion was fully established, with broad upregulation of metabolic pathways in Tmem compared to Tex cells. These results pointed toward altered use of metabolic pathways in LCMV-specific T cells in evolving chronic infection and suggested a role for dysregulated metabolism in establishing T cell exhaustion.
Glycolysis and Oxidative Phosphorylation Are Suppressed in Early Tex Cells
We next sought to test whether the transcriptional changes were linked functionally to the metabolism of LCMV-specific CD8 + T cells. At day 8 p.i., Teff cells in Arm infection had a higher extracellular acidification rate (ECAR) than CD8 + T cells from clone 13 infection (Figure 2A ), in agreement with the enrichment for glycolytic pathway genes. The basal oxygen consumption rate (OCR) was also significantly reduced compared to Arm infection (Figure 2A) . Injection of the mitochondrial decoupler FCCP allowed evaluation of the maximal respiratory capacity (MRC) and spare respiratory capacity (SRC, i.e., the difference between MRC and baseline OCR; Figures 2B and 2C ). CD8 + T cells at day 8 of clone 13 infection had reduced MRC and SRC (Figures 2C and 2D) . Thus, in addition to reduced respiration at baseline, early Tex cells displayed lower maximal respiration and SRC compared to Teff cells in Arm infection ( Figure 2D ). These results suggested suppressed glycolysis and OXPHOS at the effector stage of clone 13 infection despite the transcriptional upregulation of several metabolic pathways.
We next examined the relative contribution of FA versus glucose to cellular respiration. After mitochondrial decoupling, we blocked FA metabolism using the Cpt1a inhibitor etomoxir, as previously described for Teff and Tmem (O'Sullivan et al., 2014; van der Windt et al., 2012) . Addition of etomoxir reduced respiration by $60% in CD8 + T cells from both Arm and clone 13 infection (Figures 2F and 2G) , suggesting that at day 8 p.i., both Teff and early Tex cells could use FA as an energy source, although effects of etomoxir on other targets cannot be fully excluded. In contrast, inhibition of glycolysis using 2-DG resulted in a modest reduction in OCR in Arm, but a $50% decrease in respiration of CD8 + T cells from clone 13 infection (Figures 2E, 2H, and 2I) . 2-DG inhibits glycolysis, by blocking early glycolytic enzymes (hexokinase and phosphoglucose-isomerase) and competing for glucose transporters. Thus, these results indicated that glucose was an important energy source fueling mitochondrial respiration that was rapidly depleted in early Tex cells during clone 13, but not Arm infection at day 8 p.i. In agreement with this notion, a recently described glucose deprivation signature (Ho et al., 2015) was enriched in CD8 + T cells from clone 13 versus Arm infection at day 8 p.i. ( Figure S2A ). Glucose uptake by Teff cells in Arm peaks at day 4 p.i. and declines by day 8 p.i. around the time of antigen elimination ( Figure S2B ). The (legend continued on next page) ability to import glucose via glucose transporter-1 (Glut-1) is a limiting step for glucose use by T cells. Glucose uptake was low and linked to reduced Glut-1 on early Tex and Teff cells compared to naive T cells ( Figures 2J and 2K ). One interpretation of these observations was that while Teff cells in Arm infection have decreased their dependency on glucose mediated energy production associated with the clearance of infection and reduced TCR stimulation at day 8 p.i., CD8 + T cells in clone 13 infection remained highly dependent on glucose because of persisting antigen and TCR signaling, but were unable to maintain effector metabolism due to glucose restriction. We hypothesized that Glut-1 expression was limiting in early Tex cells. To test this idea, we transduced virus-specific TCR transgenic P14 cells specific for the LCMV GP33-41 epitope with a retrovirus (RV) expressing Slc2a1 encoding Glut-1 (Figure S3 ). As expected, increased glucose uptake was observed in vitro upon Glut-1 overexpression (OE) ( Figures S3A and S3B ). In vivo, while no major benefit was observed during Arm infection, Glut-1 OE during clone 13 infection resulted in a substantial numerical increase in Slc2a1-RV transduced P14 cells compared to control transduced cells ( Figures S3D and S3E ). Glut-1 OE also resulted in a trend toward increased glucose uptake at day 8 p.i. (p = 0.053; Figure S3E ). These data suggested that RV-mediated Glut-1 expression could enhance the CD8 + T cell response during early clone 13 infection. However, the modest increase in glucose uptake at day 8 p.i. suggested that other steps in the regulation of Glut-1 activity may also be important and that the benefit observed was either due to subtle increases in glucose uptake in vivo, or earlier events when Glut-1 OE might have a quantitatively larger impact on glucose uptake.
Metabolic Dysregulation of Early Tex Cells Involves Mitochondrial Depolarization
Mitochondrial respiration was significantly reduced in CD8 + T cells at day 8 p.i. with clone 13 ( Figure 2 ). Glucose uptake in Arm infection correlated with mitochondrial mass in Teff cells ( Figure S2C ). We thus asked whether the reduced glucose uptake and mitochondrial respiration observed in early Tex cells were linked to mitochondrial mass. Early Tex cells had significantly higher mitochondrial mass as indicated by staining with Mitotracker Green (MTG) compared to Teff cells ( Figure 3A ). These observations are in agreement with the transcriptional upregulation of mitochondrial genes (Figure 1 ), but appeared paradoxical when compared to the low mitochondrial energetics observed. Because mitochondrial membrane potential (Dcm) is required for production of ATP during OXPHOS, a low Dcm might contribute to insufficient mitochondrial function in CD8 + T cells in clone 13 infection. Thus, we combined a potentialdependent and a potential-independent mitochondrial dye to identify CD8 + T cells with depolarized mitochondria. Indeed, at day 8 p.i., a significantly higher fraction of early Tex cells had depolarized mitochondria compared to Teff cells ( Figure 3B ). Electron transmission microscopy of naive CD8 + T cells, Teff and early Tex cells identified differences in the morphology of mitochondria in early Tex cells including fused mitochondria with cristae elongation and prominent electron-lucent mitochondrial matrix ( Figure 3C ). Virus-specific CD8 + T cells with depolarized mitochondria expressed normal profiles of differentiation and exhaustion markers, such as CD44 and PD-1, but displayed reduced forward scatter suggesting smaller cell size ( Figure 3D ). T cells with depolarized mitochondria exhibited increased mitochondrial reactive oxygen species (ROS) ( Figure 3E ). Accumulation of ROS might inflict damage to cellular proteins and DNA, potentially leading to apoptosis (Belikov et al., 2015) . To test this, we used a combination of Annexin V and LD Aqua staining that allows characterization of membrane perturbation, early apoptosis and overt cell death. We used the scatter properties identified in Figure 3D to identify P14 cells with smaller cell size and assessed healthy (AnnexinV À LD À ), early apoptotic (AnnexinV + LD À ) and late apoptotic/necrotic (LD + ) phenotypes ( Figure S4 ). We observed a significant frequency of small P14 cells undergoing cell death, however, $33% of the cells analyzed showed no indication of apoptosis ( Figure S4 ). In contrast, when we analyzed the complete pool of LD À P14 cells, only 10%-15% of cells with depolarized mitochondria stained AnnexinV + . Imagestream analysis revealed intact nuclear staining of these depolarized cells ( Figure 3F ). These data suggested that depolarization of mitochondrial membrane potential results in increased ROS production, which might render a fraction of early Tex cells sensitive to death. Taken together, these results indicated that early during clone 13 infection, virus-specific CD8 + T cells displayed defects in regulation of mitochondrial metabolism including increased mitochondrial mass associated with accumulation of depolarized mitochondria and ROS production.
mTOR Signaling Contributes to Mitochondrial Depolarization in Early Tex Cells
In a scenario of continuous metabolic demand such as one developing Tex cells experience, deprivation of glucose supply (e.g., involving low Glut-1) might result in reduced mitochondrial tricarboxylic acid (TCA) cycle substrate influx and compromised membrane potential. Thus, we hypothesized that mTOR signaling persisting past the normal effector stage in early Tex cells might compromise metabolic programming. We, therefore, interrogated the ability to phosphorylate ribosomal protein S6 downstream of mTOR upon antigen stimulation. Ex vivo phosphorylation of S6 in LCMV-specific CD8 + T cells was high at day 6 p.i. with Arm or clone 13 ( Figure 4A ). In Arm infection, ex vivo pS6 returned to baseline by day 8 p.i., consistent with the control of infection. In contrast, during clone 13 infection, residual elevated ex vivo pS6 was observed at day 8 p.i., likely reflecting ongoing in vivo signaling. We next tested the potential to induce new signaling via mTOR after peptide restimulation in vitro. mTOR activity was reduced during clone 13 compared to Arm infection especially after day 8 p.i. (Figure 4A ), suggesting lack of optimal induction of mTOR signaling upon restimulation. These results are in (legend continued on next page) agreement with the recently described impairment of mTOR signaling in Tex cells in chronic infection (Staron et al., 2014) . However, mTOR pathway genes were enriched at day 8 p.i. of clone 13 infection (Figure 1 ) and the direct ex vivo difference in pS6 at day 8 p.i. suggested the possibility that ongoing residual, yet suboptimal, mTOR activity could play a role in the metabolic phenotype observed in early Tex cells. To test this idea, we treated mice with 300 mg/kg of mTOR inhibitor rapamycin from day 5-7 p.i. in clone 13 infection. This treatment mildly reduced the number of virus-specific T cells ( Figures 4B and 4C ) as expected based on the role of mTOR in effector CD8 + T cell expansion (Araki et al., 2009; Pearce et al., 2009) . Despite the impact on T cell expansion, only mild changes in typical T cell differentiation and exhaustion markers were observed in clone 13 infection ( Figure 4D ). Similar treatment promoted development of memory precursors and reduced short-lived Teff in Arm infection (data not shown) as described (Araki et al., 2009 ). Short-term treatment with rapamycin during early clone 13 infection significantly reduced mitochondrial mass and depolarization ( Figures 4E and 4F ), suggesting that persisting mTOR signaling was involved in the development of paradoxically large dysfunctional mitochondria in early Tex cells. These changes were also associated with a mild reduction in glucose uptake ( Figure 4G ) and decreased polyfunctionality of virus-specific T cells ( Figure 4F ). While limiting mTOR activity by rapamycin improved the mitochondrial fitness of early Tex cells, this metabolic benefit might come at the expense of reducing remaining effector function.
Mitochondrial and mTOR Abnormalities Persist in Tex Cells in Established Chronic Infection
During the transition to full exhaustion after the effector phase in established chronic infection, virus-specific CD8 + T cells undergo major cellular changes, including downregulation of many metabolic genes (Figure 1 ) (Wherry et al., 2007) . We therefore investigated the connections between the metabolic phenotype in early versus established chronic infection. We observed a gradual reduction in mitochondrial mass over time, accompanied by a reduction in the frequency of depolarized mitochondria ( Figures 5A-5C ). However, compared to Tmem, Tex cells maintained a slightly greater mitochondrial mass and significant increase in the proportion of depolarized mitochondria. We also investigated the basal respiration and MRC of Tex cells in established chronic infection and observed reduced respiration compared to naive T cells and Tmem ( Figures 5D and 5E ), suggesting that the functional metabolic suppression observed early is maintained throughout chronic infection.
PD1 hi and PD1 int Subsets of Tex Cells Differ Metabolically
The pool of Tex cells contains two subsets defined by expression of PD-1 and T-box transcription factors; the PD-1 Int T-bet Hi progenitor subset and the more terminally differentiated PD-1 Hi Eomes Hi subset (Blackburn et al., 2008; Paley et al., 2012) . We next tested whether the metabolic changes observed in early chronic infection were also found in PD-1 Hi and PD-1 Int Tex cell subsets in established chronic infection. Higher pS6 in the PD-1 Hi subset suggested more mTOR activity ( Figures S5A  and S5B ). Conversely, we observed higher glucose uptake and a trend to lower mitochondrial mass in PD-1 Int cells as well as an enrichment of pathways involved in glycolytic and OXPHOS metabolism compared to PD-1 Hi cells (Figures S5C-S5E) . These observations demonstrated metabolic differences between Tex cell subsets defined by PD-1 expression, but might also point toward a possible role for PD-1 in the metabolic dysfunction of Tex cells.
PD-1 Pathway Blockade Reverses Metabolic
Depression in PD-1 Int Tex Cells PD-1 blockade in tumor models is associated with transcriptional changes in metabolic genes (Gubin et al., 2014) . We next tested whether the metabolic alterations in Tex cells might be reversed by transient PD-1 pathway blockade. To address this question, we performed PD-L1 blockade in established chronic infection. PD-L1 blockade resulted in an expansion of virusspecific T cells associated with lower viral load (data not shown), as previously described (Barber et al., 2006) . After PD-L1 blockade, reinvigorated Tex cells displayed reduced mitochondrial mass and increased glucose uptake ( Figures 5F and 5G ), suggesting increased metabolic fitness. The increased glucose uptake was largely confined to the PD-1 Int Tex cell subset ( Figures 5G and 5H) . These results suggested that targeting PD-1 partially relieves metabolic restrictions, allowing the PD-1 Int progenitor population to meet the bioenergetic demands required for proliferation and reinvigoration.
PD-1 Controls Early Tex Cell Metabolism
The origins of the metabolic defects that were already present in early Tex cells described above remained unclear. We therefore tested whether PD-1 had a causal role in establishing the early metabolic dysregulation in vivo in developing Tex cells. First, we employed a co-transfer model using a small number of adoptively transferred P14 cells that allows direct comparison of WT and PD-1 deficient cells using Pdcd1 +/+ and Pdcd1 À/À P14 cells in the same host (Odorizzi et al., 2015) . This approach controls for alterations in viral load, inflammation, or immunopathology that might occur in the absence of PD-1 (Frebel et al., 2012; Odorizzi et al., 2015) . Congenically disparate Pdcd1 +/+ and Pdcd1 À/À P14 cells were adoptively transferred into WT recipient mice followed by clone 13 infection ( Figure 6A ). In this model, Pdcd1 À/À P14 cells preferentially expanded at d8 p.i. consistent with previous studies (Frebel et al., 2012; Odorizzi et al., 2015) . The numerical advantage of Pdcd1 À/À P14 cells was linked to a significant increase in glucose uptake ( Figure 6B (legend continued on next page) mitochondria ( Figures 6C and 6D) . Electron transmission microscopy of Pdcd1 +/+ and Pdcd1 À/À P14 cells highlighted a reduction in fused mitochondria, cristae elongation and translucent mitochondrial matrix in the absence of PD-1 in early Tex cells ( Figure 6E ). Of note, Pdcd1 À/À P14 cells displayed better polyfunctionality ( Figure 6F ), suggesting that improved early metabolic fitness might prevent or delay development of exhaustion. These benefits of PD-1 genetic deficiency were only observed in early infection but not in established chronic infection (Figure S5F) , consistent with the temporary benefit of PD-1 genetic deficiency on other aspects of T cell exhaustion (Odorizzi et al., 2015) . These results indicated that PD-1 acts as an upstream regulator of the metabolic phenotype in early Tex cells.
To further interrogate the effects of genetic PD-1 ablation on metabolic function, we isolated purified CD8 + T cells from Pdcd1 +/+ and Pdcd1 À/À mice at day 8 p.i. and performed metabolic flux analysis. Pdcd1 À/À CD8 + T cells had significantly higher basal respiration at day 8 p.i. with clone 13 ( Figure 6G ). We interrogated the glycolytic metabolism further by addition of glucose to previously glucose-starved cells, followed by blockade of the mitochondrial ATP synthase with oligomycin, enforcing maximal cytoplasmic glycolysis (i.e., glycolytic capacity) ( Figure 6H ). In early clone 13 infection, glycolysis and glycolytic capacity of Pdcd1 À/À cells was substantially enhanced, with Pdcd1 À/À cells resembling normal Teff cells isolated from Arm infection, while glycolytic capacity of Pdcd1 +/+ cells from clone 13 infection was strongly impaired and not different from naive non-glycolytic controls (Figure 6I, J) . Thus, these results indicated that PD-1 regulates metabolism, glycolysis and mitochondrial function of virus-specific CD8 + T cells early during clone 13 infection prior to development of full exhaustion.
Improving Early Metabolic Fitness Counteracts Developing Exhaustion
To further test the hypothesis that PD-1 regulation of metabolism contributes to exhaustion, we analyzed the expression of peroxisome proliferator-activated receptor g (PPARg) coactivator 1a (PGC-1a) ( Figure 7A ). PGC-1a is a key transcriptional regulator of genes controlling energy metabolism and mitochondrial biogenesis (Austin and St-Pierre, 2012) . PGC-1a expression was reduced in Pdcd1 +/+ compared to Pdcd1 À/À Tex cells, suggesting negative regulation of PGC-1a by PD-1 as a mechanism of metabolic modulation. PGC-1a interacts with PPARg and coordinates the expression of genes involved in mitochondrial function. Consistent with the increased respiration observed above (Figure 2) , PPAR target genes tended to be enriched in Teff from Arm infection compared to early Tex cells ( Figure 7B ). We therefore tested whether increasing PGC-1a expression could improve the metabolic fitness in chronic infection. OE of PGC-1a by RV increased potential-dependent mitochondrial staining and glucose uptake in vitro ( Figure 7C ). In vivo during clone 13 infection, Ppargc1a-transduced P14 cells had higher PGC-1a expression compared to control transduced early Tex cells ( Figures 7D and 7E ). Of note, this overexpression significantly increased polyfunctionality ( Figure 7E ). We also observed trends toward higher glucose uptake and lower PD-1 expression in early Tex cells after PGC-1a OE ( Figure 7E) . Moreover, PGC-1a OE reversed the mitochondrial phenotype of early Tex cells and substantially reduced mitochondrial mass and the frequency of cells with depolarized mitochondria ( Figure 7F ). Thus, PD-1 repressed PGC-1a and enhancing PGC-1a expression reversed metabolic perturbations associated with developing Tex cells. These data also suggested a causal link between the metabolic alterations and the development of T cell exhaustion.
DISCUSSION
Changes in metabolic gene expression of Tex cells have been observed in previous microarray studies (Wherry et al., 2007) , however it remained unclear when these changes occur and how they impact cellular metabolism. In this work, we identified functional alterations in metabolism that occurred early in chronic infection before major manifestations of exhaustion were established. For example, high mTOR activity, likely driven by persisting antigen signaling at the end of the first week of clone 13 infection, was connected to a cellular need for increased glycolysis and OXPHOS. However, early Tex cells could not meet this bioenergetic demand facing limited glucose uptake and use. This relative glucose deprivation occurred in the presence of increased anabolic signals and was controlled, at least in part, by the PD-1 pathway. This dysregulation skewed early Tex cells to an altered metabolic phenotype prone to mitochondrial depolarization and high ROS production. These defects could be partially reversed by improving glucose uptake, removing PD-1 signals or enforcing expression of the metabolic regulator PGC1a. Together, these observations implicate distorted metabolism as an upstream driver of the pathways to T cell exhaustion. Teff cells generated during acute infections switch to anabolic metabolism dominated by aerobic glycolysis (Buck et al., 2015) . In the current work, we identified suppression of glycolysis and OXPHOS early during clone 13 infection that occurred despite the transcriptional upregulation of several metabolic pathway genes, including those involved in OXPHOS. T cell commitment to exhaustion is thought to occur progressively over time Brooks et al., 2006; Crawford et al., 2014) . Early, but not established Tex cells, have developmental plasticity and could develop into functional Tmem cells if isolated during the first week, but not later in infection . One interpretation of these data is that the drivers (C) Clone 13 infected mice were treated daily from day 5-8 p.i with 300 mg/kg rapamycin (Rapa) or PBS (control) and analyzed on day 8 p.i. Frequencies of CD45.1 + P14 cells are shown. Gated on live singlet CD8 + T cells (D) P14 CD8 + T cells analyzed for expression of PD-1 and CD44 (E) Representative histograms for PD-1 or MTG of P14 CD8 + T cells from control or Rapa treated mice. (legend continued on next page) of exhaustion develop gradually as chronic infection progresses.
In the current study, early Tex cells had impaired glycolysis and respiration and this early metabolic dysregulation preceded major transcriptional, phenotypic and functional changes associated with established exhaustion. Restriction of glucose availability in the presence of persisting anabolic signaling (i.e., mTOR) appeared to be a major feature of early Tex cells. Perhaps to compensate for these defects in glycolysis, Cpt1a, a key regulator of FA oxidation (FAO) was upregulated in early Tex cells, consistent with a connection between PD-1, Cpt1a, and FAO observed in vitro (Patsoukis et al., 2015) . Blockade of Cpt1a reduced mitochondrial respiration by $50% in early Tex cells suggesting that early Tex cells have access to alternate energy pathways when glucose use is limiting. The use of FA might endow Tex cells with a survival mechanism when faced with glucose restriction, but might be insufficient to fuel anabolic metabolism normally associated with robust TCR signaling, leading to restrictions on proliferative expansion and effector function. These findings support the notion that regulation of metabolism is an early driver, rather than a consequence, of exhaustion.
Our observations also implicate PD-1 as a major control pathway of metabolic dysregulation during early and established CD8 + T cell exhaustion. In vitro studies with activated effectorlike T cells showed suppression of glycolysis by PD-1 and CTLA-4 (Parry et al., 2005; Patsoukis et al., 2015) . Despite these connections between PD-1 and glycolysis, our results suggest that inhibition of glucose uptake is incomplete. In metabolic flux experiments, glucose addition prompted an increase in glycolysis in glucose-deprived early Tex cells, whereas inhibition of residual glucose uptake by 2-DG reduced metabolic activity. In vitro approaches using activated Teff-like cells have highlighted more complete suppression of glycolysis in response to PD-1 signaling (Patsoukis et al., 2015) . Differences between in vitro studies and the current data might be due to differences between in vitro activated Teff-like cells and in vivo generated Tex cells that are transcriptionally and phenotypically distinct from Teff cells (Doering et al., 2012; Wherry et al., 2007) . Finally, while our results point to a strong connection between PD-1, metabolism and induction of T cell exhaustion, it should be pointed out that T cell exhaustion can occur even in the absence of PD-1 (Odorizzi et al., 2015) , suggesting redundancy in pathways that can drive exhaustion.
Overexpression of Glut-1 in early Tex cells improved the T cell response during early clone 13, but not Arm infection, consistent with limited glucose uptake in developing Tex cells where TCR signaling and metabolic ''stress'' on the cell persists. In vivo, the uptake of 2-NBDG peaks at $day 3-4 p.i. with LCMV Arm and then declines. This early peak in glucose uptake is consistent with other data on in vitro activated Teff-like cells (Chang et al., 2013; Maciver et al., 2008; Patsoukis et al., 2015) , but the decline in glucose uptake indicates a dynamic regulation in vivo that is distinct from short-term in vitro culture. Thus, the benefit of Glut-1 overexpression in developing Tex cells likely reflects either a role for improved glucose uptake early in the T cell expansion phase or residual low-level glucose uptake at later times. The incomplete reversal of metabolic defects and exhaustion by Glut-1 overexpression suggested that the metabolic restrictions underlying early Tex cells likely extend beyond this early glucose checkpoint. Indeed, our studies revealed PGC-1a, a central transcriptional regulator of oxidative metabolism, as a key node perturbed in developing Tex cells. PGC-1a expression was enhanced in the absence of PD-1 in early Tex cells. Overexpressing PGC-1a corrected the dysregulated mitochondrial phenotype and improved effector function, reversing hallmarks of exhaustion. Thus, in addition to previously described pathways such as Foxo1 (Staron et al., 2014) , our results now indicate that PD-1 can influence metabolic programs via PGC-1a.
Activation of mTOR downstream of TCR-triggered PI3K and Akt signaling is central for the anabolic metabolism of Teff cells, whereas limiting mTOR activity improves Tmem development in acute infection (Araki et al., 2009) . Attenuating mTOR signaling in Tex cells can arise at least partly due to PD-1 and chronic TCR stimulation (Staron et al., 2014) . This chronic stimulation results in a feedback loop in which Foxo1 sustains PD-1 expression and survival of terminal Tex cells (Staron et al., 2014) . These observations are in agreement with the decline of ex vivo S6 phosphorylation during clone 13 infection observed here and reduced pS6 following antigen stimulation in vitro. Our data also now indicate that the accumulation of paradoxically large depolarized mitochondria was due to persisting elevated or residual mTOR activity driving an anabolic mitochondrial program under conditions of nutrient restriction. One possible explanation for our findings is that in the setting of aberrant anabolic stimulation during clone 13 infection (e.g., persisting infection), mTOR signaling, although attenuated, remains stimulatory for mitochondrial biogenesis. However, this signaling occurs when glycolysis is already suppressed. Such a scenario may then cause intracellular depletion of TCA substrates, tempering the mitochondrial proton gradient, leading to mitochondrial membrane depolarization. In this model, restriction of mTOR signaling in early Tex cells by rapamycin might help adapt the nutrient demand to availability, preventing proton gradient breakdown and ROS production. In support of this notion, improving mitochondrial OXPHOS by overexpression or gain-of-function of lymphocyte expansion molecule (lem) increased virus-specific T cell function and viral control early during clone 13 infection (Okoye et al., 2015) . Despite the advantages of rapamycin treatment for the metabolic phenotype of early Tex cells, its use is unlikely to be of overall benefit in a therapeutic setting, given its immunosuppressive effects (Powell et al., 2012) . Thus, while limiting mTOR activity can benefit the mitochondrial fitness of developing Tex cells, this metabolic benefit might come at the expense of the remaining effector function.
While the characteristics of Tex cells have been defined in many settings, the early signals driving this state of T cell differentiation have remained poorly understood. The current study demonstrates metabolic control of T cell exhaustion starting early during chronic infection and implicates dysregulated metabolism as a driver of CD8 + T cell exhaustion. The PD-1 pathway constrained glucose uptake and use and repressed the key metabolic transcriptional co-activator PGC-1a, effectively suppressing glycolysis and OXPHOS in virus-specific T cells, but also compromising mitochondrial quality. These events occurred in a setting of high energetic demands leading to an altered metabolic phenotype prior to major manifestations of exhaustion. These results have implications for therapeutic strategies aiming at the reinvigoration of Tex cells in chronic infections and cancer.
EXPERIMENTAL PROCEDURES
Mice, Infections, Adoptive Transfer, and Treatments Pdcd1 À/À (Keir et al., 2007) , LCMV GP33-specific TCR transgenic ''P14,'' Pdcd1 +/+ P14 (Odorizzi et al., 2015) , and C57BL/6 mice (Charles River) were housed at the University of Pennsylvania (Philadelphia, PA) and treated in accordance with protocols approved by the Institutional Animal Care and Use Committee. Infections with LCMV Armstrong (2 3 10 5 plaque-forming units [PFU) i.p.) or clone 13 (4 3 10 6 PFU i.v.) were performed as described (Odorizzi et al., 2015) . Treatment with 300 mg/kg of rapamycin or PBS was performed daily at day 5-8 p.i. For antibody blockade, mice were injected with 200 mg anti-CD4 (GK1.5; BioXcell) i.p. on day À1 and +1 of infection; treatment with 200 mg anti-PDL1 (10F.9G2) antibody or isotype control was performed every 3 days between day 22 and 35 p.i. For cotransfer experiments, 250 Pdcd1 +/+ and Pdcd1 À/À P14 cells were adoptively transferred as described (Odorizzi et al., 2015) .
Retrovirus Experiments
Slc2a1 (encoding Glut-1) or Ppargc1a (encoding PGC1a) cDNA was cloned into the MSCV-IRES-VEX plasmid. CDNA-expressing RVs were produced in 293T cells with MSCV and pCL-Eco plasmids using Lipofectamine 3000 (Invitrogen). For RV transduction, splenic P14 cells were enriched by CD8 negative selection (StemCell). After 24 hr of activation with anti-CD3 (1 mg/ml; 2C11; eBioscience) and anti-CD28 (0.5 mg/ml; 37.51; eBioscience) with recombinant human IL-2 (100 U/ml), P14 cells were transduced with RV and polybrene (1 mg/ml) by spin infection (2,000 g for 60 min at 30C). RV-transduced P14 cells were adoptively transferred into recipient infected mice, as described (Kurachi et al., 2014) . /0.1mM) . In some experiments, cells were equilibrated in glucose-free media and injection of glucose (10 mM) was performed. SRC was defined as the difference between MRC and baseline OCR, expressed as percentage of baseline.
Gene Set Enrichment Analysis
Flow Cytometry and Cell Sorting
For mitochondrial studies, cells were incubated with 50 nM MitoTracker Green (MTG) and/or 25 nM MitoTracker DeepRed (MTDR) for 30 min at 37C prior to staining. Mitochondrial superoxides were assessed using 5 mM MitoSox Red. Glucose uptake was assayed by exposing cells to 10 mM 2-[N-(7-nitrobenz-2oxa-1,3-diazol-4-yl) amino]-2-deoxy-D-glucose (2-NBDG) at 37 C. Reagents were obtained from Life Technologies. Staining for flow cytometry was performed as described (Odorizzi et al., 2015) . Reagents were obtained from BD (Annexin V), BioLegend (CD3, CD4, CD8, CD19, CD39, CD44, CD45.1, CD45.2, CD71, CD98, CD127, CD160, PD-1), Ebioscience (CD8, CD27, CD38, CD39 CD62L, 2B4, Lag-3, KLRG1), R&D Systems (Glut-1) or Cell Signaling Technology (p-S6 240/244 ). Tetramers were obtained from the NIH tetramer core. Dead cells were excluded based on LIVE/DEAD Fixable Dead Cell Stain (Life Technologies) or Zombie NIR (Biolegend). Annexin V staining was performed as per manufacturer's protocol (BD). Data were collected on an LSRII (BD) and analyzed with FlowJo software (Tree Star). Cell sorting was performed using a FACSAria II (BD). For signaling experiments, cells were rested for 30-60 min at 37 C in 10% RPMI, followed by restimulation with 1 mM gp33 peptide for 20 min. P-S6 240/244 was detected using BD cytofix/cytoperm kit.
Polychromatic Imaging Cytometry
For Imagestream (Amnis) analysis, negative magnetic bead-purified (StemCell) CD8 + T cells were stained with antibodies and mitochondrial dyes as above.
Hoechst 33342 staining (10mM) was performed for 30 min at 37C. Single stained cells were used as compensation controls. Images were captured at 60X magnification and analysis was performed using IDEAS v6 software (Amnis).
Electron Microscopy
Samples were purified by FACS and fixed by immersion in a 2% glutaraldehyde solution in 0.1 M cacodylate buffer (pH 7.4). Processing and staining was performed as described (Picard et al., 2015) . Thin sections (90 mm) were mounted on filmed copper grids, stained with uranyl acetate and lead citrate and examined on a JEOL 1010 or FEI-Tecnai T12 electron microscope.
Statistical Analysis
Prism (GraphPad Software) and JMP (SAS Institute) were used for statistical analysis. Paired and unpaired Student's t test (as appropriate) were used in Figures 2, 3, 4 , 5, 6, and 7.
ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/gds) (GSE41867 and GSE41869). 
